Ionis Pharmaceuticals
IONS
IONS
308 hedge funds and large institutions have $6.35B invested in Ionis Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 102 increasing their positions, 103 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
2.06% more ownership
Funds ownership: 95.43% → 97.49% (+2.1%)
2% more funds holding
Funds holding: 303 → 308 (+5)
1% less repeat investments, than reductions
Existing positions increased: 102 | Existing positions reduced: 103
Holders
308
Holding in Top 10
6
Calls
$29.2M
Puts
$20.7M
Top Buyers
| 1 | +$65.2M | |
| 2 | +$52.6M | |
| 3 | +$48.4M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$38.4M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$32.7M |
Top Sellers
| 1 | -$40.5M | |
| 2 | -$36.3M | |
| 3 | -$33M | |
| 4 |
ClearBridge Investments
New York
|
-$15.7M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$11.3M |